Thomas Prud'Homme

Entrepreneur, Investor & Advisor

📍 Greater Paris Metropolitan Region, France🔄 Updated September 2026💼 31 investments📅 11 years investing🗓 Last invested May 2026𝕏 @upgrade_to_unlock
VC🌍 France20+ investmentsInvested this year
31
Total investments
21
Early stage
6
Mid stage
3
Late stage
11y
Years active

Portfolio

30 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
May 2026
In the AI Search era, being cited in the AI Answers is the new metric for brands, not clicks. We help brands and agencies fast-track AI visibility with Ads while creating new revenue streams for publishers. Powering Generative Engine Advertising (#GEA).
Investor
Jul 2025
ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.
Investor
Feb 2025
DrugOptimal propose un logiciel, extension du pharmacien, déployable en service auprès des soignants afin déviter les incompatibilités physico-chimiques médicamenteuses (IPC) en détectant les risques sur lordonnance et en proposant des solutions dadministration pour les éviter. Base de données de 105 000 couples, validée, et développée à partir dune compilation de 22 000 articles scientifiques, un modèle de prédiction des IPC par IA (+4000 paramètres physico-chimiques par couple) et notre propre laboratoire de recherche en chimie analytique (plateforme haut débit dédiée permettant danalyser plus de 1000 échantillons par jour). Notre champ daction : - Médicaments injectables : support au choix des solvants, concentrations, débits, PSE, aide à la réduction des contacts indésirables entre médicaments dans les tubulures, proposition de rampes de perfusion - Médicaments oraux : écrasabilité/section des médicaments et alternatives galéniques, interactions médicaments-aliments, modalités de prise
Investor
May 2024
Actionable is a startup specialized in predictive analysis of customer satisfaction through artificial intelligence. With its innovative platform, it provides businesses with the ability to predict the satisfaction of their entire customer base on a daily basis. By employing an innovative method that analyzes data throughout the customer journey, Actionable identifies the key factors driving this satisfaction and enables tracking of key metrics in real-time through a comprehensive dashboard and widgets. Its goal is to transform the measurement of customer satisfaction into a continuous, precise, and actionable process.
Investor
May 2024
Campsider est la destination #1 des sportifs pour séquiper en seconde main. Achetez, vendez du matériel sélectionné et garanti, en toute confiance et avec des conseils de spécialistes ! Notre mission : rendre accessible laventure en pleine nature et protéger nos terrains de jeu avec à une économie plus circulaire.
Seed Investor
Mar 2023
Iconic collectibles embodied by the greatest athletes, sports legends and clubs.
early stageSpectator Sports
Investor
Dec 2022
Location de smartphones pour les particuliers et les entreprises à partir de 19,90€/mois
Investor
Dec 2022
spyne is the first business operation platform enabling marketing and growth teams to grow their business. One place for: data, insights and collaboration, no technical ability required. Founded by 5 repeat entrepreneurs with a first hand marketing experience and in depth industry knowledge, we are on a mission to help marketers do their job and focus on what matters. Spyne manages campaigns, data aggregation, enrichment, insights, workflow management and let marketers make less errors, smarter decisions and save time. You want in ? Let’s build the future of smart marketers together!
Investor
Jul 2022
Du Private Equity aux biens de collection, Caption vous ouvre des opportunités dinvestissement uniques sur une seule et même plateforme : start-ups, franchises, montres, oeuvres dart, parts de fonds, et plus encore. --- Caption.market est une plateforme dinvestissement opérée par Caption SA, Prestataire de Services dinvestissement (PSI) agréé par lAutorité de Contrôle Prudentiel et de Résolution (ACPR) sous le numéro CIB 18683. AVERTISSEMENT : L’investissement dans des actifs non cotés présente des risques parmi lesquels la perte partielle ou totale du capital investi et l’illiquidité.
Investor
Jul 2022
xpln.ai develops new solutions for measuring and optimizing advertising effectiveness, supported by artificial intelligence, 100% cookieless, adapted to the new era of digital marketing.
Investor
Apr 2022
Bring music artist IP to gaming
Investor
Mar 2022
GETJUST reshapes the entire customer journey and make shopping simple, smart & social. Our plug-and-play checkout experience combines a high-performing fast checkout with marketing triggers, enabling merchants to increase revenues & margins by 10-15% on average. With over 500 merchants onboarded in France and +1 million users, GETJUST is on mission to serve a new generation of consumers for the next decades. Join us in shaping the new standard for simple, smart, and social shopping ✨
Investor
Mar 2022
« Rematch, le meilleur du sport amateur filmé par ses spectateurs ! » Rematch permet à ceux qui filment avec l’application sur smartphone : - De capter uniquement les meilleurs moments d’une rencontre : : il leur suffit d’appuyer sur un bouton de l’application sur l’écran du téléphone et Rematch crée une vidéo avec les 15 secondes qui précèdent leur appui ; - D’en obtenir automatiquement le montage vidéo ; - De le/les partager instantanément (sur leurs réseaux sociaux, par messagerie, mail…) ; - De les diffuser immédiatement sur les sites et pages Facebook des clubs/ligues/fédérations, des médias et supports partenaires, comme sur Rematch (site et application). Ces vidéos sont un cadeau offert à tous ceux qui veulent voir ou revoir les moments forts de leur sport depuis leur mobile, leur ordinateur... Elles participent activement à la vie de ces multitudes de communautés, sport par sport, club par club, équipe par équipe.
Investor
Feb 2022
The Enterprise SaaS platform that unlocks the full potential of your marketing data assets to deliver significant incremental revenue in retail, retail media, and media. Give your marketing team a unique data avantage. By providing our clients with a flexible, open and scalable tech backbone, we customise the solution to their needs to leverage it across all teams including marketing, sales, CRM, data and analytics to enable real-time activation across all major platforms. mediarithmics was founded in 2013, and currently works with some of the most advanced clients across Europe including Channel 4, Fnac-Darty, Havas Media, TF1, Canal+, Mulliez Group and many more.
Investor
Jan 2022
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology. At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women. Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine. Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability. Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future. 🌐 www.ziwig.com
Show all 30 investments ↓
Experience · 34 entries
All (34)
Investments (31)
Founder (2)
2026
Investor
May 2026
In the AI Search era, being cited in the AI Answers is the new metric for brands, not clicks. We help brands and agencies fast-track AI visibility with Ads while creating new revenue streams for publishers. Powering Generative Engine Advertising (#GEA).
2025
Investor
Jul 2025
ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.
Investor
Feb 2025
DrugOptimal propose un logiciel, extension du pharmacien, déployable en service auprès des soignants afin déviter les incompatibilités physico-chimiques médicamenteuses (IPC) en détectant les risques sur lordonnance et en proposant des solutions dadministration pour les éviter. Base de données de 105 000 couples, validée, et développée à partir dune compilation de 22 000 articles scientifiques, un modèle de prédiction des IPC par IA (+4000 paramètres physico-chimiques par couple) et notre propre laboratoire de recherche en chimie analytique (plateforme haut débit dédiée permettant danalyser plus de 1000 échantillons par jour). Notre champ daction : - Médicaments injectables : support au choix des solvants, concentrations, débits, PSE, aide à la réduction des contacts indésirables entre médicaments dans les tubulures, proposition de rampes de perfusion - Médicaments oraux : écrasabilité/section des médicaments et alternatives galéniques, interactions médicaments-aliments, modalités de prise
2024
Investor
May 2024
Actionable is a startup specialized in predictive analysis of customer satisfaction through artificial intelligence. With its innovative platform, it provides businesses with the ability to predict the satisfaction of their entire customer base on a daily basis. By employing an innovative method that analyzes data throughout the customer journey, Actionable identifies the key factors driving this satisfaction and enables tracking of key metrics in real-time through a comprehensive dashboard and widgets. Its goal is to transform the measurement of customer satisfaction into a continuous, precise, and actionable process.
Investor
May 2024
Campsider est la destination #1 des sportifs pour séquiper en seconde main. Achetez, vendez du matériel sélectionné et garanti, en toute confiance et avec des conseils de spécialistes ! Notre mission : rendre accessible laventure en pleine nature et protéger nos terrains de jeu avec à une économie plus circulaire.
Show all 34 entries ↓
Investment activity
2015–2026 · 31 investments
2015220164201732018320192202022022920231202422025220261
Recent (last 2 years)Earlier